Focal Segmental Glomerulosclerosis clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • Nephrotic Syndrome Study Network

    open to eligible people ages up to 80 years

    Minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and Membranous nephropathy (MN), generate an enormous individual and societal financial burden, accounting for approximately 12% of prevalent end stage renal disease (ESRD)…

    Torrance, California and other locations

Our lead scientists for Focal Segmental Glomerulosclerosis research studies include .